Protected Percutaneous Coronary Intervention With Impella 5.5 Pump in Severe Peripheral Artery Disease

View at publisher Summarise with VIRAT
Authors: Rohit B. Ponnada, Atman K. Shah, Bhanuteja Pujari, Atharva M. Bhagwat, Ladislao Marrero‐Rivera, Lolita Golemi, Shilpkumar Arora, Divya Ratan Verma, Anh-Thu Le, Hersh S. Maniar, Chien-Jung Lin
Cited by: 0
References: 10

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Mechanical circulatory support (MCS) devices can be helpful to maintain hemodynamic stability during high-risk percutaneous coronary intervention (PCI). Iliofemoral arterial disease limits the use of transfemoral MCS devices. Impella 5.5, a surgical transaxillary MCS device, represents a viable option for MCS-protected PCI. We report a 74-year-old man with prior endovascular aneurysm repair (EVAR), severe peripheral artery disease (PAD), and newly diagnosed NSTEMI was found to have three-vessel and left main coronary disease with an ejection fraction (EF) of 13%. Due to aortoiliac occlusion, transfemoral MCS was not feasible. Instead, an Impella 5.5 was implanted via a right axillary artery graft, enabling successful orbital atherectomy and bifurcation PCI. In summary, axillary Impella 5.5 insertion is a viable option in anatomically complex patients where femoral access is contraindicated. This approach allows full left ventricular hemodynamic support for revascularization in otherwise inoperable patients.

Fields of Study & Subjects

Mechanical Circulatory Support Devices Coronary Interventions and Diagnostics Vascular Procedures and Complications

Publication details

Journal / source
Catheterization and Cardiovascular Interventions
Volume
107
Issue
6
Pages
1966–1969
Publication date
22 March 2026
Language
EN